1 / 55

Review of the Medical Monitoring Project Outcomes of Interest Pilot Year Data

Review of the Medical Monitoring Project Outcomes of Interest Pilot Year Data. MMP PAB/CAB Meeting May 31, 2007 Department of State Health Services Epidemiology & Surveillance Unit Sylvia L. Odem, MPH Project Coordinator . Acknowledgements to the Pilot Year TX-MMP Team:.

corine
Télécharger la présentation

Review of the Medical Monitoring Project Outcomes of Interest Pilot Year Data

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Review of theMedical Monitoring Project Outcomes of InterestPilot Year Data MMP PAB/CAB Meeting May 31, 2007 Department of State Health Services Epidemiology & Surveillance Unit Sylvia L. Odem, MPH Project Coordinator

  2. Acknowledgements to the Pilot Year TX-MMP Team: • Katharine Carvelli, Epidemiologist • Mark Heinzke, Data Manager • Sharon K. Melville, Principal Investigator • Nita Ngo, Epidemiologist • Jim Phillips, Data Collector • Renee Ridgley, Data Collector • Tammy Sajak, Co-Principal Investigator • Jose Velez, Data Collector • Simone Wooden-Jackson, Data Collector

  3. What is the Medical Monitoring Project (MMP)? • A survey and medical chart review about the experiences and needs of people living with HIV and AIDS in the US • Behaviors • Clinical outcomes • Type and quality of care received • Identify met and unmet needs for HIV care and prevention services

  4. MMP Goals • Determine access to and use of prevention and support services • Provide local and national estimates for the population in care for HIV • Examine variations of factors by geographic area and patient characteristics (i.e. risk behaviors, quality of care etc.)

  5. How you might use the MMP data • Supplement your local needs assessments • Determine need for new programs in your organization • Use for grant applications and RFP’s • Use as a benchmark for your programs • Requests for special data runs

  6. Nationally Representative Three Stage Sampling Design • 1st stage - Site 20 states + 6 cities randomly selected • 2nd stage - Provider • 40-60 facilities randomly selected - large, medium, and small • 3rd stage - Patient • 400 randomly selected patients Chicago San Francisco New York City Philadelphia LA County Houston High Medium Alaska Hawaii Puerto Rico Low

  7. MMP Success

  8. Pilot Year – 2005 Preliminary data 13 sites Sampled 27 facilities Sampled 150 patients 81 interviews 86 chart abstractions Project Year – 2007 Full year – all 26 sites participating Sampled 47 facilities 27 recruited to-date 400 patients to be sampled 400 interviews & abstractions to be done MMP Data collection

  9. Demographics & Patient Characteristics

  10. Gender

  11. Race/Ethnicity

  12. Age by Race

  13. Age by Race (14%) (21%) (48%) (18%)

  14. Education by Race *Cell suppressed for n<3

  15. Age First Positive by Race (44%) (40%) (15%) (1%)

  16. Number of Years HIV Positive n=25 n=22 n=13 n=12 * *Cell suppressed for n<3

  17. Alcohol and Drug Use n=46 n=21

  18. Date of Last Injection and First Positive Date

  19. Frequency of Alcohol Consumption in Past 12 Months* *51% of those interviewed reported alcohol use in the past 12 months

  20. No. of Alcoholic Drinks in Typical Day in Past 30 Days

  21. Drug Use in Past 12 months *Embalming fluid

  22. Mean Number of Sexual Partners in the Past 12 months

  23. Male: Male Partner(s) • 64% of men interviewed reported having male sexual partner(s) in the past 12 months *Among men who reported having anal sex in past 12 months

  24. Male: Male Partner(s) – Last Time You Had Sex

  25. Male: Female Partner(s) • 10% (n=7) of men interviewed reported having female sexual partner(s) in the past 12 months *Cell suppressed for n<3

  26. Female: Male Partner(s) • 46% (n=6) of women had male sexual partner(s) in the past 12 months *Cell suppressed for n<3

  27. Access to Care & Need for Services

  28. Public Assistance and Homelessness in Past 12 Months n=45 n=7 *57% (n=4) of homeless were receiving public assistance

  29. Health Insurance Coverage

  30. Payment Method for HIV Meds & Other Meds in Past 12 Months

  31. Time to Start HIV Care

  32. Reasons for Delay in HIV Care • Didn’t want to think about being HIV positive (main reason) • Felt good, didn’t need to go • Too busy to go • Didn’t want to believe HIV test results • Drinking or using drugs • Fear of being socially ostracized • Felt meds were dangerous

  33. Need and Receipt of Services in the Past 12 Months

  34. Reasons for Not Receiving Services Needed • Didn’t know where to go/who to call (n=12) • Service not available in patient’s area (n=4) • Waiting list too long (n=7) • Transportation problems (n=*) • Not eligible or denied services (n=*) • Services too costly (n=*) *Cell suppressed for n<3

  35. Receipt of Prevention Activity Itemsin Past 12 Months *Percentage computed using those who had received condoms as the denominator † 25% reported ever injecting drugs, but 0% have injected drugs in the past 12 months

  36. Free Condom Source

  37. Preventive Therapies and Screenings

  38. Preventive Therapy *Only prescribed to patients who have a CD4 cell count <49.

  39. Reasons For Not Receiving Hepatitis Vaccination • Patient already has hepatitis • Doctor indicated vaccine not necessary • Patient did not believe they were at risk for contracting hepatitis • Patient doesn’t like needles • Patient was not aware vaccine was available • Patient did not complete the series

  40. Ever Tested for and Ever Had Hepatitis

  41. Prevention: Tests †Among patients who have ever had a TB skin test *Cell suppressed for n<3

  42. STD Screening in Past 12 months

  43. Female Sexual Health n=13 n=10

  44. Female Sexual Health n=12 n=11 n=12 n=11 n=5 n=5 n=5 n=5 *Among patients who ever had a PAP smear

  45. Facility Type for Last Pelvic Exam

  46. CD4, Viral Load Tests & ARV Medications

  47. CD4 and Viral Load Tests in Past 12 Months

  48. Antiretroviral Usage n=76 n=63 n=12

  49. Drug Combinations of ARV Meds Currently Using *Includes combinations such as 3 nukes and 2 PIs; 3 nukes and 1 non-nuke; 3 nukes, 2 PIs, and 1 combination drug; 2 nukes, 1 PI, and 1 combination drug; 1 nuke, 1 non-nuke, and 1 combination drug †Including combinations such as 1 nuke and 1 PI; 1 nuke and 1 non-nuke; 1 nuke and 1 combination drug

  50. Reason Never Started Antiretroviral Treatment • Doctor advised to delay treatment (main reason) • CD4 counts and/or viral load good • Felt good and didn’t need them • Concerned about side effects

More Related